ZLM-66 is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) with an IC50 of 41 nM against wild-type HIV-1 reverse transcriptase and an EC50 of 13 nM against wild-type HIV-1; it is an analog of doravirine and can be used in AIDS research.